Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 341

1.

[Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].

Stelmach-Gołdyś A, Czarkowska-Paczek B.

Przegl Lek. 2012;69(5):194-6. Review. Polish.

PMID:
23050415
2.
3.

Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.

Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.

Am J Nephrol. 2012;35(4):365-71. doi: 10.1159/000337482. Epub 2012 Apr 2.

PMID:
22473253
4.

Monoclonal gammopathies of undetermined significance.

Kyle RA, Rajkumar SV.

Best Pract Res Clin Haematol. 2005;18(4):689-707. Review.

PMID:
16026745
5.

The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.

Sigurdardottir EE, Turesson I, Lund SH, Lindqvist EK, Mailankody S, Korde N, Björkholm M, Landgren O, Kristinsson SY.

JAMA Oncol. 2015 May;1(2):168-74. doi: 10.1001/jamaoncol.2015.23.

PMID:
26181017
6.

Pathogenesis and progression of monoclonal gammopathy of undetermined significance.

Bladé J, Rosiñol L, Cibeira MT, de Larrea CF.

Leukemia. 2008 Sep;22(9):1651-7. doi: 10.1038/leu.2008.203. Epub 2008 Jul 31. Review.

PMID:
18668131
7.

[Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].

Adam Z, Krejčí M, Pour L, Sevčíková E, Křivanová A, Rehák Z, Koukalová R, Cermáková Z, Vaníček J, Sevčíková S.

Vnitr Lek. 2014 Oct;60(10):861-79. Review. Czech.

PMID:
25382009
8.

Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.

Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK.

Transplantation. 2011 Sep 15;92(5):570-4. doi: 10.1097/TP.0b013e318225db2c.

PMID:
21712755
9.
10.

Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.

Greenberg AJ, Rajkumar SV, Vachon CM.

Blood. 2012 Jun 7;119(23):5359-66. doi: 10.1182/blood-2011-11-387324. Epub 2012 Feb 21. Review.

11.

Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.

Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.

Ann Hematol. 2002 Jul;81(7):357-61. Epub 2002 Jul 11.

PMID:
12185503
12.

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Kyle RA, Rajkumar SV.

Hematol Oncol Clin North Am. 2007 Dec;21(6):1093-113, ix.

PMID:
17996590
13.
14.

[Monoclonal gammopathy of undetermined significance].

Chaïbi P, Merlin L, Thomas C, Piette F.

Ann Med Interne (Paris). 2002 Nov;153(7):459-66. Review. French.

PMID:
12598832
15.

Monoclonal gammopathy of undetermined significance.

Kyle RA.

Blood Rev. 1994 Sep;8(3):135-41. Review.

PMID:
7819815
16.

[Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients].

Salgado C, Bladé J, López-Guillermo A, Cervantes F, Montserrat E, Rozman C.

Sangre (Barc). 1993 Oct;38(5):371-4. Spanish.

PMID:
8140498
17.

Monoclonal gammopathy of undetermined significance (MGUS).

Kyle RA.

Baillieres Clin Haematol. 1995 Dec;8(4):761-81. Review.

PMID:
8845571
18.

[Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].

Ruiz-Delgado GJ, Gómez Rangel JD.

Gac Med Mex. 2004 Jul-Aug;140(4):375-9. Spanish.

PMID:
15456147
19.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M; International Myeloma Working Group.

Leukemia. 2010 Jun;24(6):1121-7. doi: 10.1038/leu.2010.60. Epub 2010 Apr 22. Review.

PMID:
20410922
20.

Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.

Iwanaga M, Tomonaga M.

Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):18-20. doi: 10.1016/j.clml.2013.12.010. Epub 2013 Dec 19.

PMID:
24461807

Supplemental Content

Support Center